Giacomo Di Tella

AI Assistants for business teams — driving daily decisions and actions that create measurable business value. The most advanced, fully integrated platform — proven to outperform market leaders. #sales #management #support #product #sales

Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale. Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.

FlyFree Airways Progetto di sviluppo di una piattaforma di Flight Sharing on demand in real time Nel nostro sito potrete trovare informazioni generiche sul nostro progetto in costruzione. Potete contattarci in privato per approfondire. Il nostro progetto FlyfreeAirways.it è stato anche selezionato per partecipare alla competion price di Heroes 2018 a Maratea. Ecco tutti i progetti innovativi selezionati: http://bit.ly/selezionate_2018 Potete chiederci la presentazione e il business plan in qualunque momento semplicemente scrivendoci nel modulo contatti di questo sito oppure scrivendo a info@resultsadv.it GRAZIE a tutti i nostri sostenitori #flyfreeairways #feditalimpresepiemonte #goheroes2018

Reusable in-space transportation: launch, operate, return, repeat.

ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.

From living biological batteries below earth that generate energy, save water and compensate heat; to bioluminescent plants, able to reduce energy use and light pollution; and even biological activators, using leaves to create automations between the human beings and plants, are some of the unique biotechnologies developed in our labs. Bioo is ideating, installing and developing buildings and parks around the planet by becoming its biotech partner, not only incorporating the first system in the world that recovers the economical investment of its green areas, but also providing a real symbiosis between nature and technology while absorbing CO2. All, without damaging any living being in the process, and enhancing our natural ecosystems. We move towards the next biotech revolution.

Investi. Impara. Cresci. Unisciti al club di investimento privato Akka, fondato da imprenditori e investitori di prestigio, e scopri le opportunità di investimento nelle startup più esclusive in Europa! Gli investimenti comportano rischi e non vi è alcuna garanzia di rendimento. Informati bene prima di investire.

AI Assistants for business teams — driving daily decisions and actions that create measurable business value. The most advanced, fully integrated platform — proven to outperform market leaders. #sales #management #support #product #sales

Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale. Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.

FlyFree Airways Progetto di sviluppo di una piattaforma di Flight Sharing on demand in real time Nel nostro sito potrete trovare informazioni generiche sul nostro progetto in costruzione. Potete contattarci in privato per approfondire. Il nostro progetto FlyfreeAirways.it è stato anche selezionato per partecipare alla competion price di Heroes 2018 a Maratea. Ecco tutti i progetti innovativi selezionati: http://bit.ly/selezionate_2018 Potete chiederci la presentazione e il business plan in qualunque momento semplicemente scrivendoci nel modulo contatti di questo sito oppure scrivendo a info@resultsadv.it GRAZIE a tutti i nostri sostenitori #flyfreeairways #feditalimpresepiemonte #goheroes2018

Reusable in-space transportation: launch, operate, return, repeat.

ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.